NEW YORK (GenomeWeb News) — GeneGo said today that that the National Institute of Diabetes and Digestive and Kidney Diseases has renewed its MetaCore license to continue researching insulin-resistant diabetes in human and animal models.
Tatiana Nikolskaya, chief scientific officer and president of GeneGo, said the collaboration "is a very important part of our development program in this field."
Financial details were not disclosed.